STOCK TITAN

LH insider Form 144: 5,745-share sale notice via Fidelity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Laboratory Corporation of America Holdings (LH) reported a Form 144 notice of a proposed sale of 5,745 common shares, with an aggregate market value of $1,509,498.75. The filing lists Fidelity Brokerage Services LLC as broker, an approximate sale date of 11/11/2025, and the NYSE as the exchange. Shares outstanding were 82,900,000.

The shares to be sold were acquired through restricted stock vesting on 02/02/2024 (1,911 shares), 02/07/2024 (2,101 shares), and 02/11/2024 (1,733 shares). The filing also shows a recent transaction by a named seller: Adam H. Schechter sold 5,643 shares on 08/11/2025 for $1,505,439.54 in gross proceeds.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 notice for a modest insider share sale.

This Form 144 lists a proposed sale of 5,745 LH common shares with an aggregate market value of $1,509,498.75, routed through Fidelity and intended for the NYSE. The shares earmarked for sale were acquired via restricted stock vesting on three February 2024 dates, indicating equity compensation being monetized.

Form 144 is a notice requirement for affiliates under Rule 144 and does not itself execute the sale. The excerpt also notes a prior sale on 08/11/2025 of 5,643 shares for $1,505,439.54. Actual trading activity will depend on market conditions and affiliate constraints under Rule 144.

This appears administrative and typical for equity compensation. No use-of-proceeds or company cash flow is involved; transactions occur for the selling holder’s account.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many LH shares are covered by this Form 144 notice?

The notice covers a proposed sale of 5,745 common shares.

What is the aggregate market value of the proposed LH share sale?

The aggregate market value listed is $1,509,498.75.

When is the approximate sale date for the LH shares?

The approximate sale date is 11/11/2025.

Which broker and exchange are listed for the LH share sale?

Broker: Fidelity Brokerage Services LLC; Exchange: NYSE.

How were the LH shares to be sold originally acquired?

Through restricted stock vesting on 02/02/2024, 02/07/2024, and 02/11/2024.

How many LH shares were sold in the past three months and for how much?

5,643 shares were sold on 08/11/2025 for $1,505,439.54 in gross proceeds.

What are LH shares outstanding as listed in the notice?

Shares outstanding were 82,900,000.
Labcorp Holdings Inc

NYSE:LH

LH Rankings

LH Latest News

LH Latest SEC Filings

LH Stock Data

22.74B
81.71M
Diagnostics & Research
Services-medical Laboratories
Link
United States
BURLINGTON